spacer
home > pmps > autumn 2018 > managing medication
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Managing Medication

Medication nonadherence is a serious public health issue. It costs the NHS approximately £500 million every year, as well as countless hours of work dealing with problems which arise due to patients not taking prescribed medications as directed. As the former US general surgeon, Dr C Everett Koop, stated, “drugs don’t work in patients who don’t take them.”

Across the UK, one billion items are prescribed and dispensed by pharmacists every year. However, one in five patients surveyed as part of the True Cost of Medication Non- Adherence report admitted to not taking their medication as prescribed. “Non-adherence is a big problem,” Ric Fordham, Professor of Applied Health and Economics at the University of East Anglia, UK, said in the study. “When patients don’t feel ill, or they start to feel better, they think there is no need for them to take their drugs anymore. Patients then don’t get the full benefit of them and that ends up reducing the cost effectiveness of the drugs.”

Nonadherence can be classified as intentional (when a patient actively decides not to take medication or follow treatment recommendations) or unintentional (which can be caused by misunderstanding the prescription requirements, an inability to access or administer prescribed medication, or simple forgetfulness). The National Institute for Health and Care Excellence states that nonadherence should not be considered as just the patient’s problem; ultimately, it represents a fundamental limitation in the delivery of healthcare.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Oliver Pittock is the Managing Director of pharmaceutical packaging specialist, Valley Northern. Oliver built his commitment to the healthcare and pharmacy supply business through seeing his father’s business grow throughout the 1970s. Moving to the Midlands in 1993, Oliver set up Valley Northern, which became a limited company in 2014.
spacer
Oliver Pittock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement